BioSpace News Archive

Policy

IRS Investigating Bristol Myers Squibb Over Tax Scheme Worth $1.4 Billion

In a statement, the company said, “Bristol Myers Squibb is in compliance with all applicable tax rules and regulations. We work with leading experts in this area and will continue to work cooperatively with the IRS to resolve this matter. Beyond that, we don’t comment on ongoing regulatory matters.”

April 1, 2021
·
3 min read
·
Mark Terry
Pharm Country

CDMO Error Ruins Batch of J&J COVID-19 Vaccines

A manufacturing mistake at Emergent Biosolutions ruined a 15 million-dose batch of Johnson & Johnson’s Vaxzevria in production.

April 1, 2021
·
2 min read
·
Mark Zipkin
Could Opdivo be a New Standard in Esophageal Cancer Therapy?

In a large-scale research study published today in The New England Journal of Medicine (NEJM), Dr. David Ilson reported on the potential of Opdivo (adjuvant nivolumab) as a treatment for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma.

April 1, 2021
·
2 min read
·
Kristiane Polido
Deals

Eloxx Acquires Zikani with Hopes to Rule the RNA Wave for Rare Disease

Eloxx Pharma has experienced a string of changes over the past year, coming to a head with today’s announcement that the company will be acquiring early-stage biotech Zikani Therapeutics in an all-stock deal.

April 1, 2021
·
3 min read
·
Kate Goodwin
Policy

FDA Panel Takes Another Swing at Biogen’s Alzheimer’s Candidate

Three members of the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee published their objections to the drug in a JAMA article.

April 1, 2021
·
4 min read
·
Mark Terry
Business

CDC Ranks COVID-19 as Third Leading Cause of Death in 2020

Several new reports, two by the U.S. CDC, describe just how severely COVID-19 has affected mortality figures in the U.S., and around the world, as well as ripple effects that extended to other forms of death.

April 1, 2021
·
4 min read
·
Mark Terry
Business

JLL Report Ranks Up-and-Coming Life Sciences Hubs

New markets are emerging, and a new report from the market research team at JLL pinpoints some of these growing areas.

April 1, 2021
·
3 min read
·
Alex Keown
BioForest

BioSpace Movers & Shakers: Precigen, Amylyx, BeiGene and More

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

April 1, 2021
·
6 min read
·
Alex Keown
FDA

FDA Says Yes to Two New Drugs for Cancer and High Blood Pressure

The U.S. Food and Drug Administration approved two new treatments for multiple myeloma and pulmonary hypertension.

April 1, 2021
·
3 min read
·
Alex Keown
Genetown

Arranta Bio Aims for Bold Innovation in Microbiome Space

For more than a decade, team members of Watertown, Mass.-based Arranta Bio have been studying the physical and functional characteristics of Live Biotherapeutic Products.

April 1, 2021
·
2 min read
·
Alex Keown